Home / Digestive tract and metabolism / Insulin (Human)
ATC A10AC01 · Insulins and Analogues for Injection, Intermediate-Acting
Insulin (Human) shortage
As of 2 Nov 2026, Insulin (Human) has a reported shortage in 1 of the 15 countries we track (Canada), covering 1 product from 1 company.
Countries1/15
Products1packs or presentations
Companies11 listed
Short since–
Earliest return18 Apr 2027company estimate
Main reasonNot stated
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage
Which companies are short
products short, all countriesListed: Eli Lilly LLY · NYSE
Affected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | HUMULIN N (Vial HI0310, 10 mL, 100 units/mL) discontinuation | ELI LILLY CANADA INC | not given | 18 Apr 2027 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.